The transcription factor MEF2A plays a key role in the differentiation/maturation of rat neural stem cells into neurons by Zhu, Bangfu et al.
                          Zhu, B., Carmichael, R., Solabre Valois, L., Wilkinson, K., & Henley, J.
(2018). The transcription factor MEF2A plays a key role in the
differentiation/maturation of rat neural stem cells into neurons. Biochemical
and Biophysical Research Communications, 500(3), 645-649.
https://doi.org/10.1016/j.bbrc.2018.04.125
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1016/j.bbrc.2018.04.125
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Elsevier at
https://www.sciencedirect.com/science/article/pii/S0006291X18309045?via%3Dihub . Please refer to any
applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
lable at ScienceDirect
Biochemical and Biophysical Research Communications 500 (2018) 645e649Contents lists avaiBiochemical and Biophysical Research Communications
journal homepage: www.elsevier .com/locate/ybbrcThe transcription factor MEF2A plays a key role in the differentiation/
maturation of rat neural stem cells into neurons
Bangfu Zhu 1, 2, Ruth E. Carmichael 2, Luis Solabre Valois, Kevin A. Wilkinson,
Jeremy M. Henley*
School of Biochemistry, Centre for Synaptic Plasticity, University of Bristol, BS8 1TD, UKa r t i c l e i n f o
Article history:
Received 10 April 2018
Accepted 16 April 2018







Transcription factor* Corresponding author.
E-mail address: j.m.henley@bristol.ac.uk (J.M. Hen
1 Present address: Department of Cellular and Mol
2 These authors contributed equally to this work.
https://doi.org/10.1016/j.bbrc.2018.04.125
0006-291X/© 2018 The Authors. Published by Elseviea b s t r a c t
Neural stem cells (NSCs) are self-renewing multipotent stem cells that can be proliferated in vitro and
differentiated into neuronal and/or glial lineages, making them an ideal model to study the processes
involved in neuronal differentiation. Here we have used NSCs to investigate the role of the transcription
factor MEF2A in neuronal differentiation and development in vitro. We show that although MEF2A is
present in undifferentiated NSCs, following differentiation it is expressed at signiﬁcantly higher levels in a
subset of neuronal compared to non-neuronal cells. Furthermore, shRNA-mediated knockdown of MEF2A
reduces the number of NSC-derived neurons compared to non-neuronal cells after differentiation. Together,
these data indicate that MEF2A participates in neuronal differentiation/maturation from NSCs.
© 2018 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The highly conserved myocyte enhancer factor 2 (MEF2) family
of proteins were ﬁrst described as the transcription factors required
for differentiation of myoblasts to myocytes in vertebrate muscle
development [1]. It has subsequently been shown that they coor-
dinate expression of a range of proteins in all eukaryotic cells [2] by
controlling target gene transcription through the direct recruit-
ment of a range of transcriptional co-activators [3] and co-
repressors [4]. As a result, MEF2 proteins regulate a wide variety
of cellular pathways including apoptosis and coordination of tissue-
speciﬁc functions [5].
The four vertebrate MEF2 isoforms are classiﬁed MEF2A-D. Each
isoform is comprised of highly conserved N-terminal MADS
(MCM1-Agamous-Deﬁciens-SRF) and MEF2 domains that mediate
the DNA binding and dimerization required for function, and a
variable C-terminal transcriptional transactivation domain [6].
All MEF2 isoforms are extensively expressed in the brain [7].
Interestingly, however, deﬁned expression patterns during pre- and
postnatal development suggest each isoform may have distinctley).
ecular Physiology, Institute of Tran
r Inc. This is an open access articleroles at different stages of neuronal maturation. For example, while
MEF2C expression remains relatively constant, MEF2A and D
expression increases as neurons differentiate and mature [8].
Genome-wide analysis and functional characterization of cultured
neurons has identiﬁed multiple MEF2-regulated genes associated
with neuronal and synaptic development [9,10]. MEF2A in partic-
ular is highly expressed in neurons during synaptogenesis and
plays important roles in the control of pre- and postsynapse for-
mation [9e13]. Inducible Mef2a, -c, and -d knockout mice for
temporal and cell-speciﬁc MEF2 deletion have been used to
monitor the progression of hippocampal adult neural stem/pro-
genitor cells, and have shown that each knockout can generate
mature neurons. However, these neurons exhibit stunted dendrites,
suggesting possible roles for MEF2 proteins in the control of adult
hippocampal neurogenesis and dendritogenesis in vivo [14].
In this study, we focused on the roles of MEF2A in deﬁning the
differentiation, maturation and fate of NSCs in culture. We show
that both undifferentiated and differentiated NSCs express MEF2A,
with a subset of neuronally differentiated cells expressing signiﬁ-
cantly more MEF2A than their non-neuronal counterparts.slational Medicine, University of Liverpool, L69 3GE, UK.
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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proportion of NSCs that differentiate into neurons.
2. Methods
2.1. Molecular biology
Cloning of all constructs was carried out using standard mo-
lecular biology methods. An shRNA sequence targeting rat MEF2A
(GGGCAGTTATCTCAGGGTTCAA) or a non-targeting control
(AATTCTCCGAACGTGTCAC) under the control of a H1 promoter
were cloned into a modiﬁed form of the pXLG3 vector [15,16]
expressing an EGFP marker.
2.2. Cell culture
NSCs were isolated from E14 Wistar rat embryos. Forebrain
areas were dissected and dissociated with StemPro Accutase solu-
tion (Gibco), before being seeded into culture ﬂasks. Cells were
initially grown as neurospheres in proliferation media (DMEM/F-12
media þ B27 supplement (Gibco), 1  Insulin-Transferrin-Sodium
Selenite Supplement (Gibco), 1  Non-Essential Amino Acids So-
lution (Gibco), 20 ng/ml of each EGF/bFGF (Preprotech),
1  penicillin/streptomycin (Sigma Aldrich)).
For NSC differentiation, the media was replaced with differen-
tiation media (proliferation media lacking EGF and bFGF and sup-
plemented with 200 mM Ascorbic acid (Sigma Aldrich)) and the
cells were plated on PDL-coated glass coverslips.
All neural cell transfections were performed using Lipofect-
amine 2000 (Invitrogen) according to the manufacturer's
instructions.
2.3. Immunocytochemistry and immunoﬂuorescence imaging
Immunocytochemistry assays were performed withFig. 1. NSC culture and differentiation.
A). NSCs were isolated from rat embryonic brains and grown as neurospheres.
B). NSCs were identiﬁed by immunostaining with the neural stem cell marker Nestin (red)
C). Following withdrawal of growth factors, NSCs are induced to differentiate.
D). Immunostaining showing differentiation of NSCs into neurons (Tuj1 staining in red) anparaformaldehyde ﬁxation according to standard protocols [17].
Brieﬂy, cells were ﬁxed using 4% PFA before or after differentiation
and permeabilised using Triton 100 (0.1%). 10% horse serum in
PBS was used to block cells and antibody staining was performed
with the following antibodies: Nestin (rabbit polyclonal, Sigma-
Aldrich SAB4200394, 1:500), Tuj1 (mouse monoclonal, Sigma-
Aldrich T8578, 1:200), GFAP (rabbit monoclonal, Cell Signaling
Technologies 12389, 1:200), MEF2A (rabbit monoclonal, Abcam
ab109420, 1:100). The secondary antibodies were Cy3 donkey anti-
rat IgG and/or Cy2 donkey anti-mouse IgG (Molecular Probe, Invi-
trogen). The samples then were mounted in Fluoromount-G
mounting medium (eBioscience Inc.). Nuclei were counterstained
with diamidino-2-phenylindole (DAPI).
All immunoﬂuorescence images were taken using a Leica SP5-II
confocal laser scanning microscope attached to a Leica DMI 6000
inverted epiﬂuorescence microscope (Wolfson Bioimaging Facility,
University of Bristol), and processed and analysed using ImageJ
software.
2.4. Data analysis
All quantiﬁed data are presented as the mean± SEM from at
least three independent cultures, and where necessary results were
normalised to the average of the control values (set to 100%) for
each batch of cells. Statistical analysis was performed using
Graphpad Prism software (Graphpad Inc.). Statistical signiﬁcance
was placed at a p value of less than 0.05.
3. Results and discussion
3.1. MEF2A is expressed in undifferentiated and differentiated NSCs
MEF2A is highly expressed in the brain where it plays key roles
in neuronal maturation, dendritic morphogenesis and synapse
formation [5,8,9,12]. However, it has not been reported if MEF2A is. Nuclei were stained with DAPI (blue).
d glia (e.g. astrocytes in green with GFAP staining).
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the expression of MEF2A in both undifferentiated and differenti-
ated NSCs by immunocytochemistry. Rat NSCs isolated from E14
embryonic forebrains and cultured in DMEM/F12 medium sup-
plemented with growth factors (bFGF2 and EGF) proliferate rapidly
to form neurospheres (Fig. 1AeB) [18]. On growth factor with-
drawal they then differentiate into neurons and glial cells
(Fig. 1CeD).
We stained forMEF2A in undifferentiated NSCs and after growth
factor withdrawaleevoked differentiation (Fig. 2). AlthoughMEF2A
is expressed in the nuclei of undifferentiated NSCs, the expression
level appears to be relatively heterogeneous within the population
(Fig. 2A). MEF2A is also present in differentiated cells after 4 days of
growth factor withdrawal and the mean expression level is signif-
icantly higher in the nuclei of Tuj1-positive neuronally differenti-
ated cells, compared to neighbouring Tuj1-negative cells
(Fig. 2BeC), suggesting that, as a population, MEF2A expression is
increased in neuronal compared to non-neuronal cells.
However, since MEF2A expressionwas not increased in all Tuj1-
positive cells compared to nearby Tuj1-negative cells, weFig. 2. MEF2A expression in NSCs.
A). MEF2A (red) is present in undifferentiated NSCs, although the relative levels of express
B). MEF2A (red) is expressed at a signiﬁcantly higher level in Tuj1-positive neurons (gree
staining is shown with DAPI (blue).
C). Quantiﬁcation of MEF2A expression in Tuj1-positive and -negative cells following differe
negative cells from each, one-sample t-test p¼ 0.034.
D). Cumulative frequency of MEF2A expression in differentiated Tuj1-negative (black line)
negative and 145 Tuj1-positive cells from 5 independent cultures.wondered whether differentiation into neurons increased the
proportion of cells expressing comparatively high levels of MEF2A.
To examine this directly, we analysed MEF2A expression in indi-
vidual Tuj1-positive and Tuj1-negative differentiated cells and
present our data as a cumulative frequency graph (Fig. 2D). Our data
show that although some Tuj1-positive differentiated cells express
low levels of MEF2A, the shift to the right on the cumulative fre-
quency plot demonstrates that a much greater proportion of
differentiated Tuj1-positive neuronal cells express higher levels of
MEF2A compared to differentiated Tuj1-negative cells. Together,
these imaging data indicate that expression of a differentiated
neuronal marker correlates with higher levels of nuclear MEF2A,
particularly within a subpopulation of neuronally differentiated
cells. This suggests that MEF2A could play a role in the formation,
maintenance or function of NSC-derived neurons.
3.2. MEF2A promotes NSC differentiation/maturation into neurons
To deﬁne if MEF2A is involved in driving NSCs towards a
neuronal lineage, we next transfected undifferentiated NSCs 24 hion appear variable.
n), as opposed to surrounding Tuj1-negative cells, in differentiated cultures. Nuclear
ntiation. n¼ 5 independent cultures analysing 20e40 Tuj1-positive and 50e100 Tuj1-
and Tuj1-positive (green line) cells. The data quantify MEF2A expression in 670 Tuj1-
Fig. 3. MEF2A knockdown reduces NSC differentiation into neurons.
A). Map of the transfection vector, expressing an
shRNA (either a MEF2A-speciﬁc shRNA or a non-speciﬁc control) under a H1 promoter as well as GFP under a SFFV promoter as a reporter of transfection.
B & C). NSCs transfected with non-speciﬁc shRNA (B) or MEF2A-speciﬁc shRNA (C) prior to differentiation, stained for MEF2A (red) and Tuj1 (blue). Example transfected cells (GFP-
positive) are highlighted by white arrowheads.
D). MEF2A expression in NSCs transfected with MEF2A shRNA was almost completely ablated compared to NSCs transfected with a non-speciﬁc shRNA (n¼ 5 independent cultures
analysing 14 transfected cells per condition in total, Student's unpaired t-test p¼ 0.0002).
E). Fewer MEF2A shRNA transfected cells differentiated into Tuj1-positive neurons compared to NSCs transfected with a non-speciﬁc shRNA control (n¼ 3 independent cultures
analysing 30e40 transfected cells per condition from each, Student's unpaired t-test p< 0.0001).
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expression of endogenous MEF2A, and GFP to identify transfected
cells (Fig. 3A).
Although transfection levels are relatively low, typically ~5% of
NSCs, this is an advantage for imaging studies because it allows
direct comparison of transfected (GFP-expressing, green) and non-
transfected (non-green) NSCs on the same coverslip.
Untransfected cells show strong endogenous MEF2A staining, as
seen previously (Fig. 3B and C). However, MEF2A staining was not
detectable in any cells transfected with the shRNA targetingMEF2A
(Fig. 3C, quantiﬁed in Fig. 3D), consistent with a recent report
showing that this MEF2A shRNA construct is highly effective at
knocking down MEF2A expression in rat neurons by Western
blotting and immunoﬂuorescence [19]. In contrast, cells transfected
with control non-speciﬁc shRNA show strong endogenous MEF2A
immunostaining comparable to levels in untransfected cells
(Fig. 3B).
Quantitative analysis of these data demonstrate that following
growth factor withdrawal for 4 days, only 9.2± 0.8% of NSCs
transfected with the MEF2A shRNA developed into Tuj1-positive
cells compared to 37.5± 1.4% of NSCs transfected with the non-
speciﬁc shRNA control (Fig. 3E), indicating that MEF2A promotes
a neuronal phenotype following NSC differentiation.
Since rat NSCs can differentiate into neurons or glia in vitro, they
are a useful model to investigate neuronal differentiation and
development. Consistent with a report that MEF2A expression in-
creases as cerebellar granule neurons differentiate and mature,
which is marked by neurite growth [8], we show that MEF2A is
present in NSCs and differentiated cultures, with signiﬁcantly
elevated expression in differentiated neurons. In addition, we
demonstrate that shRNA knockdown of MEF2A decreases NSC dif-
ferentiation to neural stem/progenitor cell-derived neurons, sup-
porting the notion that MEF2A drives NSC differentiation into
neurons in vitro.
We propose that the transcriptional activity of MEF2Amakes it a
likely regulator of the changes in gene expression that underpin
neuronal differentiation of NSCs. However, our present data do not
rule out the alternative possibility that MEF2A could be important
for the development or survival of Tuj1-positive neurons after
differentiation. Indeed, it has previously been reported that inhi-
bition of MEF2 in cultured cortical neurons leads to apoptotic cell
death, suggesting that MEF2 is necessary for neuronal survival,
particularly of newly-differentiated neurons [20,21].
The mechanisms of how MEF2A might regulate the differenti-
ation/survival of neurons during brain development, and how it is
itself regulated, are the subject of intensive research. In synapse
development, for example, the transcriptional activity of MEF2A
may be modulated by posttranslational modiﬁcations such as
phosphorylation and/or SUMOylation [9,10]. Further research is
needed to resolve howMEF2A is controlled on a temporal and cell-
type speciﬁc level to regulate its roles in development.
Nonetheless, our data are the ﬁrst demonstration that MEF2A is
expressed in embryonic brain-derived NSCs cultured in vitro and
plays a role in their differentiation into a neuronal phenotype. Thus,
we conﬁrm and extend previous studies demonstrating the
importance of MEF2A as an arbiter of neuronal development and
maturation. These ﬁndings are of potential importance because
NSCs can be rapidly grown and easily manipulated so deeperunderstanding of the factors driving NSC differentiation could open
new avenues to develop novel cell replacement therapies.
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